Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
Zanfina Ademi, Danny Liew, Alexandra Gorelik, Megan Bohensky, Ella Zomer, Bruce Hollingsworth, Gabriel Steg, Deepak L Bhatt, Christopher M Reid
International Journal of Cardiology | ELSEVIER IRELAND LTD | Published : 2014
The global REACH Registry is sponsored by Sanofi-Aventis, Bristol-Myers Squibb and the Waksman Foundation (Tokyo, Japan), and is endorsed by the World Heart Federation. The REACH Registry enforces a no-ghost-writing policy. The sponsors provide logistical support. All manuscripts in the REACH Registry are led by independent authors who are not governed by the funding sponsors and are reviewed by an academic publication committee before submission. The funding sponsors have the opportunity to review manuscript submissions but do not have authority to change any aspect of a manuscript. A complete list of the REACH Registry Investigators appears in JAMA. 2006; 295(2): 180-189.